You are here: Industry Insights > Series C financing

News List

Insilico Medicine Raises $255 Million in Series C Financing Led by Warburg Pincus prnasia
June 23, 2021
Insilico Medicine, a global leader in end-to-end artificial intelligence for target discovery, small molecule chemistry, and clinical development, announced that it has closed a $255 million Series C financing led by Warburg Pincus.
Hummingbird Bioscience Raises US$125 Million in Series C Financing prnasia
May 19, 2021
Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets to improve treatment outcomes, announced the close of its US$125 million Series C financing round.
AnchorDx Completes USD 40 Million Series C Financing to Advance Cancer Screening and Early Detection Programs prnasia
February 23, 2021
AnchorDx Medical Co., Ltd. announced the completion of a USD 40 million Series C financing. This round of financing was jointly led by OrbiMed, a world-renowned biomedicine and healthcare venture capital fund, and WuXi Huiying Investment ...
Affinivax secures $226m in Series C financing to boost MAPS vaccine pipeline pharmaceutical-business-review
January 12, 2021
Clinical-stage biopharmaceutical company Affinivax has secured $226m in Series C financing to advance the development of new vaccines with its multiple antigen presenting system (MAPS) platform.
ImmVira Announces Series C Financing with Leading Specialist Investors prnasia
January 04, 2021
ImmVira Group Company, a biotechnology platform dedicated to the development of oncolytic virus and vector type approaches to create more effective and safer therapies against cancer, announced the signing of Series C financing.
HiFiBiO Therapeutics Closes $67 M Series C Financing biospectrumasia
September 04, 2019
The firm will now Build on Recent Success and Advance Pipeline of Novel Antibody Drugs for Cancer and Autoimmune Disorders
InventisBio closes $70M series C financing biospectrumasia
March 18, 2019
InventisBio Inc., a clinical stage biotech company, announced the closing of a $70 million USD Series C financing in January 2019. This round of investment was co-led by Advantech Capital and CMBI, followed by Pudong Innotek. Also participating were exist
Orchard Therapeutics raises $150 M to improve Gene Therapy Pipeline biospectrumasia
August 14, 2018
Proceeds to advance three late-stage programs towards registration, prepare for commercialization and progress the company’s gene therapy platform